Skip to content

FineMark National Bank & Trust: CIBR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of FineMark National Bank & Trust on CIBR, newest first. How the timeline and the estimate are built.

FineMark National Bank & Trust held 9,348 CIBR shares at 2025-12-31 per its 13F-HR filed 2026-02-12.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 9,348 shares
    Change vs previous 13F +400 shares

    0.02% of the 13F portfolio, value $667,914.

    13F-HR 0001537720-26-000002 filed by FineMark National Bank & Trust
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-09-30
    13F 8,948 shares
    Change vs previous 13F -24 shares

    0.02% of the 13F portfolio, value $680,137.

    13F-HR 0001537720-25-000015 filed by FineMark National Bank & Trust
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 8,972 shares
    Change vs previous 13F -500 shares

    0.02% of the 13F portfolio, value $678,103.

    13F-HR 0001537720-25-000011 filed by FineMark National Bank & Trust
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 9,472 shares
    Change vs previous 13F +6,097 shares

    0.02% of the 13F portfolio, value $596,736.

    13F-HR 0001537720-25-000008 filed by FineMark National Bank & Trust
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 3,375 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $214,143.

    13F-HR 0001537720-25-000002 filed by FineMark National Bank & Trust
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).